Old Web
English
Sign In
Acemap
>
authorDetail
>
Jeannette Lynne Hasapidis
Jeannette Lynne Hasapidis
Entinostat
Medicine
non-small cell lung cancer (NSCLC)
Myeloid-derived Suppressor Cell
Melanoma
2
Papers
13
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Preliminary results of ENCORE 601, a phase 1b/2, open-label study of entinostat (ENT) in combination with pembrolizumab (PEMBRO) in patients with non-small cell lung cancer (NSCLC).
2016
Journal of Clinical Oncology
Melissa Lynne Johnson
Alex A. Adjei
Suresh S. Ramalingam
Pasi A. Jänne
George A. Dominguez
Dmitry I. Gabrilovich
Laura Deleon
Jeannette Lynne Hasapidis
Scott J. Diede
Peter Ordentlich
Matthew D. Hellmann
Show All
Source
Cite
Save
Citations (10)
A phase 1 study to assess the food effect on the pharmacokinetics (PK) of entinostat.
2014
Journal of Clinical Oncology
Denise A. Yardley
Suzanne F. Jones
Peter Ordentlich
Carol J. Braun
Helen S. Pentikis
Jeannette Lynne Hasapidis
Miranda Rees
Howard A. Burris
Show All
Source
Cite
Save
Citations (3)
1